ESTROGENS AND THROMBOEMBOLIC DISEASES
1976; Informa; Volume: 55; Issue: S54 Linguagem: Inglês
10.3109/00016347609156445
ISSN1600-0412
Autores Tópico(s)Blood Coagulation and Thrombosis Mechanisms
ResumoActa Obstetricia et Gynecologica ScandinavicaVolume 55, Issue S54 p. 13-28 ESTROGENS AND THROMBOEMBOLIC DISEASES Present conception of a controversial issue Göran Zador M.D., Corresponding Author Göran Zador M.D. Medical Department, Schering Nordiska AB, Nacka, SwedenSchering Nordiska AB, Fack, S-131 01 Nacka, SwedenSearch for more papers by this author Göran Zador M.D., Corresponding Author Göran Zador M.D. Medical Department, Schering Nordiska AB, Nacka, SwedenSchering Nordiska AB, Fack, S-131 01 Nacka, SwedenSearch for more papers by this author First published: January 1976 https://doi.org/10.3109/00016347609156445Citations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Allan T. M.. ABO blood-groups and venous thromboembolism. Lancet 1971; 2: 1209. 10.1016/S0140-6736(71)90533-2 CASPubMedWeb of Science®Google Scholar Anderson T. W.. Oral contraceptives and female mortality trends. Can Med Assoc J 1970; 102: 1156. CASPubMedWeb of Science®Google Scholar Ask-Upmark E.. Thromboembolism and oral contraceptives, post or propter?. Acta Med Scand 1966; 179: 463. 10.1111/j.0954-6820.1966.tb05484.x CASPubMedWeb of Science®Google Scholar Badaracco M. A., Vessey M. P.. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J 1974; 1: 215. 10.1136/bmj.1.5901.215 CASPubMedWeb of Science®Google Scholar Bingel A. S., Benoit P. S.. Oral contraceptives: Therapeutics versus adverse reactions with an outlook for the future. J Pharm Sci 1973; 62: 179. 10.1002/jps.2600620202 CASPubMedWeb of Science®Google Scholar Brakman P., Sobrero A. J., Astrup T.. Effects of different systemic contraceptives on blood fibrinolysis. Am J Obstet Gynecol 1970; 106: 187. 10.1016/0002-9378(70)90261-9 CASPubMedGoogle Scholar Brody S.. Obstetrik och Gynekologi. Almqvist & Wiksells Förlag AB, Stockholm 1974; 827. Google Scholar Böttiger L. E., Westerholm B.. Oral contraceptives and thromboembolic disease–Swedish experience. Acta Med Scand 1971; 190: 455. 10.1111/j.0954-6820.1971.tb07459.x CASPubMedWeb of Science®Google Scholar Cahal D. A.. Oral contraceptives and thromboembolic episodes. Brit Med J 1965; 2: 1180. 10.1136/bmj.2.5461.590-b PubMedWeb of Science®Google Scholar Conard J., Samama M., Salomon Y.. Antithrombin III and the oestrogen content of combined oestro-progestogen contraceptives. Lancet 1972; 2: 1148. 10.1016/S0140-6736(72)92757-2 PubMedWeb of Science®Google Scholar Crombie D. L., Cross K. W.. Oral contraceptives and thromboembolism. Br Med J 1969; 3: 654. 10.1136/bmj.3.5671.654-a CASPubMedWeb of Science®Google Scholar Doll R.. New pill on trial. 1973, General Practitioner April 13. Google Scholar Drill V. A., Calhoun D. W.. Oral contraceptives and thromboembolic disease. JAMA 1968; 206: 77. 10.1001/jama.1968.03150010025004 CASPubMedWeb of Science®Google Scholar Drill V. A., Calhoun D. W.. Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives. JAMA 1972; 219: 583. CASPubMedWeb of Science®Google Scholar “FDA Report on the Oral Contraceptives”. FDA Advisory Committee on Obstetrics and Gynecology, Washington, D.C. 1966. Google Scholar Frederiksen H., Ravenholt R. T.. Thromboembolism, oral contraceptives and cigarettes. Public Health Report 1970; 85: 197. 10.2307/4593826 PubMedWeb of Science®Google Scholar Freiman D. G., Suyemoto J., Wessler S.. Frequency of pulmonary thromboembolism in man. N Engl J Med 1965; 272: 1278. 10.1056/NEJM196506172722406 CASPubMedWeb of Science®Google Scholar Fuertes de la Haba A., Curet J. O.C., Pelegrina I., Bangdiwala I.. Thrombophlebitis among oral and non-oral contraceptive users. Obstet Gynecol 1971; 38: 259. CASPubMedWeb of Science®Google Scholar Goldzieher J. W.. Oral contraceptives: A review of certain metabolic effects and an examination of the question of safety. Fed Proc 1970; 29: 1220. CASPubMedWeb of Science®Google Scholar Goldzieher J. W., Maqueo M., Chenault C. B., Woutersz T. B.. Comparative studies of ethinyl estrogens. I. Endometrial effects. Am J Obstet Gynecol 1975; 122: 615. 10.1016/0002-9378(75)90060-5 CASPubMedWeb of Science®Google Scholar Goldzieher J. W., de la Pena A., Chenault C. B., Woutersz T. B.. Comparative studies of ethinyl estrogens. II. Inhibition of ovulation. Am J Obstet Gynecol 1975; 122: 619. 10.1016/0002-9378(75)90061-7 CASPubMedWeb of Science®Google Scholar Goldzieher J. W., de la Pena A., Chenault C. B., Cervantes A.. Comparative studies of ethinyl estrogens. III. Effects on plasma gonadotropins. Am J Obstet Gynecol 1975; 122: 625. 10.1016/0002-9378(75)90062-9 CASPubMedWeb of Science®Google Scholar Goldzieher J. W., Dozier T. S.. Oral contraceptives and thromboembolism: A reassessment. Am J Obstet Gynecol 1975; 123: 878. 10.1016/0002-9378(75)90866-2 CASPubMedWeb of Science®Google Scholar Hagenfeldt K.. Fakta om preventivmedel. Socialstyrelsens Nämnd för Hälsoupplysning. 1974. Google Scholar Hedlin A. M., Monkhouse F. C.. Changes in spontaneous fibrinolytic activity during use of oral contraceptives. Obstet Gynecol 1971; 37: 225. CASPubMedWeb of Science®Google Scholar Hougie C.. Thromboembolic disorders and oral contraceptives. JAMA 1969; 208: 865. 10.1001/jama.1969.03160050119022 CASPubMedWeb of Science®Google Scholar Hougie C.. Thromboembolism and oral contraceptives. Am Heart J 1973; 85: 538. 10.1016/0002-8703(73)90501-2 PubMedWeb of Science®Google Scholar Inman W. H.W., Vessey M. P.. Investigation of death from pulmonary, coronary and cerebral thrombosis and embolism in women in childbearing age. Br Med J 1968; 2: 192. 10.1136/bmj.2.5599.193 PubMedGoogle Scholar Inman W. H.W., Vessey M. P., Westerholm B., Engelund A.. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; 2: 203. 10.1136/bmj.2.5703.203 CASPubMedWeb of Science®Google Scholar Jeffcoate T. N.A. R.C.O.G. statement on oral contraceptives. Br Med J 1970; 2: 293. 10.1136/bmj.2.5704.293 CASPubMedWeb of Science®Google Scholar Jick H., Slone O., Westerholm B., Inman W. H.W., Vessey M. P., Shapiro S., Levis G. P., Worcester J.. Venous thromboembolic disease and ABO blood type. Lancet 1969; 1: 539. 10.1016/S0140-6736(69)91955-2 PubMedWeb of Science®Google Scholar Jordan W. M.. Pulmonary embolism. Lancet 1961; 2: 1146. 10.1016/S0140-6736(61)91061-3 Web of Science®Google Scholar von Kaulla E., Droegemueller W., Aoki N., von Kaulla K. N.. Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynecol 1971; 109: 868. PubMedWeb of Science®Google Scholar Ludwig H.. Das Thrombophlebitisrisk bei hormonaler Kontrazeption. Ther Umsch 1971; 28: 516. PubMedGoogle Scholar Mishell D. R.. Controversy in Obstetrics and Gynecology, D. E. Reid, C. D. Christian. W.B. Saunders, Philadelphia 1974; 320. Google Scholar Morell M. T., Dunnhill M. S.. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55: 347. 10.1002/bjs.1800550506 CASPubMedWeb of Science®Google Scholar Moses L. E.. Oral contraceptives and thromboembolism. JAMA 1969; 208: 694. 10.1001/jama.1969.03160040102021 PubMedWeb of Science®Google Scholar Mourant A. E., Kopec A. C., Domaniewska-Sobczak K.. Blood-groups and blood-clotting. Lancet 1971; 1: 223. 10.1016/S0140-6736(71)90961-5 CASPubMedWeb of Science®Google Scholar Nilsson I. M., Åstedt B.. Blood clotting and contraception. Br Med J 1971; 2: 589. 10.1136/bmj.2.5761.589-c CASPubMedWeb of Science®Google Scholar Peacock P. B.. The non-comparability of relative risks from difficult studies. Biometrics 1971; 27: 903. 10.2307/2528827 Web of Science®Google Scholar Poller L., Thomson J. M.. Sequential oral contraception and clotting factors. Br Med J 1969; 2: 822. 10.1136/bmj.2.5660.822-b CASPubMedWeb of Science®Google Scholar Poller L., Thomson J. M., Thomas W.. Oestrogen/progestogen oral contraception and blood clotting: A long-term follow-up. Br Med J 1971; 4: 648. 10.1136/bmj.4.5788.648 CASPubMedWeb of Science®Google Scholar Population Reports: Oral contraceptives. Series A, No 2, Dept. of Medical and Public Affairs, The G. Washington University Medical Center, Washington, D.C. March, 1975. Google Scholar Royal College of General Practitioners. Oral contraception and thromboembolic disease. J R Coll Gen Practic 1967; 13: 267. PubMedGoogle Scholar Royal College of General Practitioners. Oral contraception study. Oral contraceptives and health; an interim report. Pitman Medical, London 1974. Google Scholar Råd och anvisningar, Socialstyrelsen. Peroral antikonception. September, 1971. Google Scholar Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E.. Thromboembolism and oral contraceptives: An epidemiologic case-control study. Am J Epidemiol 1969; 90: 365. 10.1093/oxfordjournals.aje.a121082 CASPubMedWeb of Science®Google Scholar Seigel D. G.. The use of historical data and adverse reaction reporting systems for epidemiologic study. Am J Epidemiol 1971; 94: 210. CASPubMedWeb of Science®Google Scholar Seigel D. G., Markush R. E.. Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States. Am J Epidemiol 1969; 90: 11. CASPubMedWeb of Science®Google Scholar Speroff L., Glass R. N., Kase N. G.. Clinical Endocrinology and Infertility. The Williams & Wilkins Co., Baltimore 1974; 152. Google Scholar Spona J., Schneider W. H.F. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive. Acta Obstet Gynecol Scand 1976; 45, Suppl 54. 10.3109/00016347609156448 PubMedWeb of Science®Google Scholar Tausk M.. Pharmakologie der Hormone. G. Thieme Verlag, Stuttgart 1970; 132. Google Scholar Tietze C., Lewit S.. Studies in Family Planning 1972; 3: 97. 10.2307/1965375 Web of Science®Google Scholar Tyler E. T.. Oral contraception and venous thrombosis. JAMA 1963; 185: 131. 10.1001/jama.1963.03060020091034 CASWeb of Science®Google Scholar Vessey M. P., Doll R.. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J 1968; 2: 199. 10.1136/bmj.2.5599.199 CASPubMedWeb of Science®Google Scholar Vessey M. P., Doll R.. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J 1969; 2: 651. 10.1136/bmj.2.5658.651 CASPubMedWeb of Science®Google Scholar Westerholm B.. Incidence of thromboembolism in oral contraceptive users in the United Kingdom and Scandinavia. Sexualhormone und Blutgerinnung 1971; 213, Suppl 50. Google Scholar Westerholm B.. Thromboembolism and oral contraceptives. Current Problems in Fertility, A. Ingelman-Sundberg, N.-O. Lunell. Plenum Press, New York 1971; 181. 10.1007/978-1-4615-8651-7_32 Google Scholar Westerholm B., Wiechel B., Eklund G.. Oral contraceptives, venous thromboembolic disease, and ABO blood type. Lancet 1971; 2: 664. 10.1016/S0140-6736(71)80108-3 CASPubMedWeb of Science®Google Scholar Wright J. S.. FDA report on Enovid, Ad Hoc Advisory Committee for the evaluation of a possible etiologic relation with thromboembolic conditions. JAMA 1963; 185: 776. 10.1001/jama.1963.03060100056018 PubMedGoogle Scholar Ygge J., Brody S., Korsan-Bengtsen K., Nilsson L.. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Am J Obstet Gynecol 1969; 104: 87. CASPubMedWeb of Science®Google Scholar Zimmerman T. S., Adelson L., Ratnoff O. D.. Pulmonary embolism and unexpected death in supposedly normal persons. A second look. N Engl J Med 1970; 28: 1504. 10.1056/NEJM197012312832706 Web of Science®Google Scholar Åstedt B., Isacson S., Nilsson L M., Pandolfi M.. Thrombosis and oral contraceptives: Possible predisposition. Br Med J 1973; 4: 631. 10.1136/bmj.4.5893.631 CASPubMedWeb of Science®Google Scholar Åstedt B.. New aspects of the thrombogenic effect of oral contraceptives. Am Heart J 1975; 90: 1. 10.1016/0002-8703(75)90249-5 PubMedWeb of Science®Google Scholar Citing Literature Volume55, IssueS54January 1976Pages 13-28 ReferencesRelatedInformation
Referência(s)